THE RECONSTITUTION VEHICLE
P-EARLs™ 0.5 mL reconstitution, pH and pI engineering
Lyoprester SS™ keeps its two actives dry and separated until the moment of use. The price of that stability is that the hardest chemistry happens last: in the seconds after activation, one 0.5 mL vehicle must dissolve a peptide layer and a vitamin layer into a single, short-lived, injectable preparation. That vehicle is P-EARLs™.
The scientific role
The 0.5 mL P-EARLs™ vehicle is being engineered specifically for this dual-layer formulation. Its scientific role is to reconcile or neutralise pH-, pI-, ionic-strength- and solubility-related conflicts during rapid reconstitution, allowing both layers to form one short-lived injectable preparation immediately before use. The 0.5 mL figure is both the P-EARLs chamber volume and the intended final reconstitution volume.
This is an engineering objective under evaluation. It is not claimed that all pH and pI conflicts have already been eliminated.
What “reconcile the conflicts” means concretely
- pH landing zone — the reconstituted liquid must arrive at a pH compatible with both peptide stability and thiamine stability for the intended hold time.
- pI avoidance — the vehicle must keep the peptide away from the isoelectric region where solubility collapses and aggregation accelerates.
- Ionic strength and tonicity — the final preparation must be both chemically workable and physiologically tolerable for subcutaneous administration.
- Solubility synchronisation — two layers with different dissolution behaviour must both clear completely within the reconstitution window, without particulates.
The measurements that decide it
P-EARLs earns its place on quantitative readouts: reconstitution time and completeness at 0.5 mL; visible and sub-visible particulates; osmolality; pH of the reconstituted preparation; post-reconstitution hold time; and local tolerance. Until those data exist, every statement on this page is an objective — and the site says so wherever the objective is described.